We have entered into license agreements with Sanofi and AbbVie, pursuant to which, among other things, we have secured exclusive licenses for certain intellectual property and know-how relating to CF…
Reciprocal relationship from ABBV graph: Reciprocal relationship from SION graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from SION graph: Reciprocal relationship from ABBV g…
We have entered into license agreements with Sanofi and AbbVie, pursuant to which, among other things, we have secured exclusive licenses for certain intellectual property and know-how relating to CF…
Sionna Therapeutics, Inc. Customers
No clients on recordNo downstream customers found in our database for Sionna Therapeutics, Inc..
Sionna Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SION-DEBT-12541
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
SION-DEBT
Debt stack $8.4M
90%
Market cache reports total debt of $8.4M.
Sionna Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Sionna Therapeutics, Inc..
Sionna Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
SION-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 122 tracked holders.
Sionna Therapeutics, Inc. Extended Supply Chain Network